NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity

• Published in: The Journal of biological chemistry Vol. 300; no. 3; p. 105681
• Main Authors: Yan, Xiao, Kuang, Bo-Hua, Ma, Shengsuo, Wang, Ruihua, Lin, Jinzhong, Zeng, Yi-Xin, Xie, Xiaoduo, Feng, Lin
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2024
• Subjects: Akt; Cell Line; Humans; Mechanistic Target of Rapamycin Complex 1 - metabolism; Mechanistic Target of Rapamycin Complex 2 - genetics; Mechanistic Target of Rapamycin Complex 2 - metabolism; mTORC2; NOP14; Protein Kinase Inhibitors - pharmacology; Proto-Oncogene Proteins c-akt - genetics; Proto-Oncogene Proteins c-akt - metabolism; rapalog; ribosome; Ribosomes - metabolism; Sirolimus - pharmacology; TOR Serine-Threonine Kinases - genetics; TOR Serine-Threonine Kinases - metabolism; rapalog; NPC; NOP14; eIF4E; TAP; OS; 4EBP; S6K; NOC4L; Akt; IRS; ER; BYSL; DFS; CHX; DMFS; mTOR; ribosome; HA; PIP3; mTORC2; PM; PDK1
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/j.jbc.2024.105681

The mechanistic target of rapamycin (mTOR) forms two distinct complexes: rapamycin-sensitive mTOR complex 1 (mTORC1) and rapamycin-insensitive mTORC2. mTORC2 primarily regulates cell survival by phosphorylating Akt, though the upstream regulation of mTORC2 remains less well-defined than that of mTORC1. In this study, we show that NOP14, a 40S ribosome biogenesis factor and a target of the mTORC1-S6K axis, plays an essential role in mTORC2 signaling. Knockdown of NOP14 led to mTORC2 inactivation and Akt destabilization. Conversely, overexpression of NOP14 stimulated mTORC2-Akt activation and enhanced cell proliferation. Fractionation and coimmunoprecipitation assays demonstrated that the mTORC2 complex was recruited to the rough endoplasmic reticulum through association with endoplasmic reticulum-bound ribosomes. In vivo, high levels of NOP14 correlated with poor prognosis in multiple cancer types. Notably, cancer cells with NOP14 high expression exhibit increased sensitivity to mTOR inhibitors, because the feedback activation of the PI3K-PDK1-Akt axis by mTORC1 inhibition was compensated by mTORC2 inhibition partly through NOP14 downregulation. In conclusion, our findings reveal a spatial regulation of mTORC2-Akt signaling and identify ribosome biogenesis as a potential biomarker for assessing rapalog response in cancer therapy.